Cue Biopharma, Inc. - 8-K Filing
Cue Biopharma reports Q3 2026 net loss of $50.0 million and revenue decline to $0.1 million driven by clinical expansion costs. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $CUE